Tokyo Tape
Sign in
← ReproCELL

Quarterly report · Q3

4978.TEDINET S100ST0T
Period2023-04-01 → 2023-12-31
Filed2024-02-09
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 34
MetricValuePeriodScopeSource row
Revenue¥1.8bn2023-04-01 → 2023-12-31Cons.Net sales
Revenue¥3.0bn2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥2.2bn2022-04-01 → 2022-12-31Cons.Net sales
Operating income−¥289m2023-04-01 → 2023-12-31Cons.Operating income
Operating income−¥207m2022-04-01 → 2022-12-31Cons.Operating income
Ordinary income¥58m2023-04-01 → 2023-12-31Cons.Ordinary income
Ordinary income−¥120m2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income−¥37m2022-04-01 → 2022-12-31Cons.Ordinary income
Profit before tax¥50m2023-04-01 → 2023-12-31Cons.Income before income taxes
Profit before tax−¥37m2022-04-01 → 2022-12-31Cons.Income before income taxes
Net income (owners)¥48m2023-04-01 → 2023-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)−¥305m2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)−¥39m2022-04-01 → 2022-12-31Cons.Profit loss attributable to owners of parent
Net income¥48m2023-04-01 → 2023-12-31Cons.Profit loss
Net income−¥39m2022-04-01 → 2022-12-31Cons.Profit loss
Total assets¥8.4bnat 2023-12-31Cons.Assets
Total assets¥8.4bnat 2023-03-31Cons.Assets
Total assets¥8.3bnat 2022-12-31Cons.Total assets (5-year summary)
Total liabilities¥627mat 2023-12-31Cons.Liabilities
Total liabilities¥781mat 2023-03-31Cons.Liabilities
Net assets / equity¥7.7bnat 2023-12-31Cons.Net assets
Net assets / equity¥7.6bnat 2023-03-31Cons.Net assets
Net assets / equity¥7.7bnat 2022-12-31Cons.Net assets (5-year summary)
Cash and deposits¥2.4bnat 2023-12-31Cons.Cash and deposits
Cash and deposits¥1.9bnat 2023-03-31Cons.Cash and deposits
EPS (basic)¥0.572023-04-01 → 2023-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-0.152023-10-01 → 2023-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-3.622022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-0.472022-04-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-1.272022-10-01 → 2022-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥0.572023-04-01 → 2023-12-31Cons.Diluted earnings per share (5-year summary)
Equity ratio92.4%at 2023-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio90.7%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio93.3%at 2022-12-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 20
SegmentItemPeriodValue
Reconciling Itemsreconcilingsegment ordinary income2023-04-01 → 2023-12-31−¥396m
jpcrp040300-q3r_E27585-000Medical Businessreportable segmentrevenue2023-04-01 → 2023-12-31¥265m
jpcrp040300-q3r_E27585-000Medical Businessreportable segmentrevenue external2023-04-01 → 2023-12-31¥265m
jpcrp040300-q3r_E27585-000Medical Businessreportable segmentsegment ordinary income2023-04-01 → 2023-12-31¥190m
jpcrp040300-q3r_E27585-000Research Support Businessreportable segmentrevenue2023-04-01 → 2023-12-31¥1.5bn
jpcrp040300-q3r_E27585-000Research Support Businessreportable segmentrevenue external2023-04-01 → 2023-12-31¥1.5bn
jpcrp040300-q3r_E27585-000Research Support Businessreportable segmentsegment ordinary income2023-04-01 → 2023-12-31¥264m
—segment totalrevenue2023-04-01 → 2023-12-31¥1.8bn
—segment totalrevenue external2023-04-01 → 2023-12-31¥1.8bn
—segment totalsegment ordinary income2023-04-01 → 2023-12-31¥454m
Reconciling Itemsreconcilingsegment ordinary income2022-04-01 → 2022-12-31−¥440m
jpcrp040300-q3r_E27585-000Medical Businessreportable segmentrevenue2022-04-01 → 2022-12-31¥866m
jpcrp040300-q3r_E27585-000Medical Businessreportable segmentrevenue external2022-04-01 → 2022-12-31¥866m
jpcrp040300-q3r_E27585-000Medical Businessreportable segmentsegment ordinary income2022-04-01 → 2022-12-31¥204m
jpcrp040300-q3r_E27585-000Research Support Businessreportable segmentrevenue2022-04-01 → 2022-12-31¥1.4bn
jpcrp040300-q3r_E27585-000Research Support Businessreportable segmentrevenue external2022-04-01 → 2022-12-31¥1.4bn
jpcrp040300-q3r_E27585-000Research Support Businessreportable segmentsegment ordinary income2022-04-01 → 2022-12-31¥200m
—segment totalrevenue2022-04-01 → 2022-12-31¥2.2bn
—segment totalrevenue external2022-04-01 → 2022-12-31¥2.2bn
—segment totalsegment ordinary income2022-04-01 → 2022-12-31¥404m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 343
ItemContextValueUnit
Income before income taxesPrior1YTDDuration-36567000JPY
Income before income taxesCurrentYTDDuration49836000JPY
Income taxes currentPrior1YTDDuration2924000JPY
Income taxes currentCurrentYTDDuration1502000JPY
Income taxesPrior1YTDDuration2924000JPY
Income taxesCurrentYTDDuration1502000JPY
Profit lossPrior1YTDDuration-39491000JPY
Profit lossCurrentYTDDuration48333000JPY
Profit loss attributable to owners of parentPrior1YTDDuration-39491000JPY
Profit loss attributable to owners of parentCurrentYTDDuration48333000JPY
Profit lossPrior1YTDDuration-39491000JPY
Profit lossCurrentYTDDuration48333000JPY
Valuation difference on available for sale securities net of tax ociPrior1YTDDuration-40503000JPY
Valuation difference on available for sale securities net of tax ociCurrentYTDDuration79048000JPY
Foreign currency translation adjustment net of tax ociPrior1YTDDuration12568000JPY
Foreign currency translation adjustment net of tax ociCurrentYTDDuration18235000JPY
Share of other comprehensive income of associates accounted for using equity method ociPrior1YTDDuration1028000JPY
Share of other comprehensive income of associates accounted for using equity method ociCurrentYTDDuration6630000JPY
Other comprehensive incomePrior1YTDDuration-26906000JPY
Other comprehensive incomeCurrentYTDDuration103914000JPY
Comprehensive incomePrior1YTDDuration-66397000JPY
Comprehensive incomeCurrentYTDDuration152248000JPY
Comprehensive income attributable to owners of the parentPrior1YTDDuration-66397000JPY
Comprehensive income attributable to owners of the parentCurrentYTDDuration152248000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q3r_E27585-000ResearchSupportBusinessReportableSegmentsMember1356901000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q3r_E27585-000MedicalBusinessReportableSegmentsMember866376000JPY
Revenues from external customersPrior1YTDDuration_ReportableSegmentsMember2223277000JPY
Revenues from external customersPrior1YTDDuration_ReconcilingItemsMember－JPY
Revenues from external customersPrior1YTDDuration2223277000JPY
Net salesPrior1YTDDuration_jpcrp040300-q3r_E27585-000ResearchSupportBusinessReportableSegmentsMember1356901000JPY
Net salesPrior1YTDDuration_jpcrp040300-q3r_E27585-000MedicalBusinessReportableSegmentsMember866376000JPY
Net salesPrior1YTDDuration_ReportableSegmentsMember2223277000JPY
Net salesPrior1YTDDuration_ReconcilingItemsMember－JPY
Net salesPrior1YTDDuration2223277000JPY
Ordinary incomePrior1YTDDuration_jpcrp040300-q3r_E27585-000ResearchSupportBusinessReportableSegmentsMember199672000JPY
Ordinary incomePrior1YTDDuration_jpcrp040300-q3r_E27585-000MedicalBusinessReportableSegmentsMember204198000JPY
Ordinary incomePrior1YTDDuration_ReportableSegmentsMember403870000JPY
Ordinary incomePrior1YTDDuration_ReconcilingItemsMember-440438000JPY
Ordinary incomePrior1YTDDuration-36567000JPY
Revenues from external customersCurrentYTDDuration_jpcrp040300-q3r_E27585-000ResearchSupportBusinessReportableSegmentsMember1512111000JPY
Revenues from external customersCurrentYTDDuration_jpcrp040300-q3r_E27585-000MedicalBusinessReportableSegmentsMember264654000JPY
Revenues from external customersCurrentYTDDuration_ReportableSegmentsMember1776765000JPY
Revenues from external customersCurrentYTDDuration_ReconcilingItemsMember－JPY
Revenues from external customersCurrentYTDDuration1776765000JPY
Net salesCurrentYTDDuration_jpcrp040300-q3r_E27585-000ResearchSupportBusinessReportableSegmentsMember1512111000JPY
Net salesCurrentYTDDuration_jpcrp040300-q3r_E27585-000MedicalBusinessReportableSegmentsMember264654000JPY
Net salesCurrentYTDDuration_ReportableSegmentsMember1776765000JPY
Net salesCurrentYTDDuration_ReconcilingItemsMember－JPY
Net salesCurrentYTDDuration1776765000JPY
Ordinary incomeCurrentYTDDuration_jpcrp040300-q3r_E27585-000ResearchSupportBusinessReportableSegmentsMember264363000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-03-31pass
balance sheet identityconsolidated 2023-12-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-12-31pass
statement vs summary · revenueconsolidated 2022-04-01/2022-12-31pass
statement vs summary · revenueconsolidated 2023-04-01/2023-12-31pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-12-31pass